Close
Smartlab Europe
Achema middle east

Yuvraj

Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with Vemurafenib for Treatment of Patients with BRAF V600 Mutation-Positive Advanced Melanoma

FDA Grants Priority Review, Assigns Action Date of August 11, 2015 - SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (NASDAQ:EXEL) announced today that the...

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor...

Patheon Adds New Filling Technology to Milton Park Facility

Patheon has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its facility in Milton...

Patheon Development and Manufacturing Presentation at Global Summit

An expert from Patheon will highlight the company's strategy for delivering exceptional customer experience through its integrated offerings at the Seventh Annual Global Biomanufacturing...

Lonza Announces Agreement for the Supply of TiGenix’s eASC Product Cx601

Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase III...

Boehringer Ingelheim Renews Global Technology Collaboration Agreement with VTU Technology

Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global...

TxCell reports revenues for 2014 and updates on upcoming milestones

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »